bioscrip inc focus provid home
altern site infus therapi via platform
reason report
estim chang analysi sales/earn
y/i adjust myriad sale oper initi
industri get relief cure act acceler
take revenu million
take revenu million
million y/i ebitda million
compani aspir number
import disclosur analyst certif page report access current disclosur stephen
inc cover compani client may refer
though compani focus optim process reduc number center
encouragingli bio exit juli million cash hand ebitda improv back half inventori
cure act relief
discount back
thousand except per share
total revenu
sell gener administr expens
depreci amort
incom continu oper
pre-tax incom loss continu oper
net incom loss continu oper
accru dividend prefer stock
deem dividend prefer stock
net incom loss common
product revenu
servic revenu
total revenu
sell gener administr expens
compani report stephen inc
analyst primarili respons prepar content report certifi view express report
accur reflect analyst person view subject compani secur ii part analyst compens
directli indirectli relat specif recommend view express analyst report
